Wegovy vs. Phentermine
See how Wegovy and Phentermine compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Wegovy is a weekly injection approved for long-term weight management and cardiovascular risk reduction, while phentermine is a daily pill approved only for a few weeks of use.
Wegovy produces greater average weight loss in clinical trials but costs significantly more and carries a boxed warning for thyroid tumors.
Phentermine is inexpensive and works fast but is a controlled substance meant only for short-term use, not chronic weight management.
Wegovy vs. Phentermine Drug Summary
Wegovy
Wegovy (semaglutide) is a GLP-1 receptor agonist injected once a week under the skin. It's FDA-approved for chronic weight management in adults and adolescents 12 and older with obesity or overweight plus a weight-related condition, and to lower cardiovascular risk in adults with heart disease and excess weight. Treatment starts at a low dose and increases gradually over about four months.
Phentermine
Phentermine is an oral sympathomimetic approved in 1959 for short-term weight loss, typically prescribed for just a few weeks alongside diet and exercise. It works like a mild amphetamine, suppressing appetite by stimulating the central nervous system. Unlike Wegovy, it isn't intended for long-term or chronic weight management.
Wegovy vs. Phentermine Side Effects
Wegovy
Phentermine
Wegovy vs. Phentermine Dosage
Wegovy
Phentermine
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 2.4 mg once weekly | Week 17 onward |
| Dose changes | 4 increases | Every 4 weeks |
| STAGE | DOSE | WHEN |
| Starting dose | 37.5 mg once daily | At the start |
| Maximum dose | 15 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Wegovy
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 2.4 mg once weekly | Week 17 onward |
| Dose changes | 4 increases | Every 4 weeks |
Phentermine
| STAGE | DOSE | WHEN |
| Starting dose | 37.5 mg once daily | At the start |
| Maximum dose | 15 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Wegovy vs. Phentermine Indications
Wegovy
Wegovy is approved for chronic weight management in adults and adolescents 12 and older who have obesity, or overweight with at least one weight-related condition, when combined with diet and exercise. It's also approved to lower the risk of major cardiovascular events like heart attack, stroke, or cardiovascular death in adults with established heart disease and obesity or overweight. This dual approval sets it apart from most other weight-loss medications.
Adults with obesity (BMI ≥30)
Adolescents 12+ and adults with overweight plus a weight-related condition
Adults with heart disease and excess weight, to reduce cardiovascular risk
Used long-term alongside diet and exercise
Phentermine
Phentermine is approved as a short-term adjunct for weight reduction in adults with obesity, or with a BMI of 27 or higher plus a weight-related risk factor. It's meant to be used for only a few weeks alongside exercise, behavioral changes, and calorie restriction. It is not approved for long-term or chronic weight management, and not for use in patients 16 and younger.
Adults with obesity (BMI ≥30)
Adults with BMI ≥27 plus a weight-related risk factor
Short-term use only, typically a few weeks
Used alongside diet, exercise, and behavior changes
Wegovy vs. Phentermine Pros and Cons
Wegovy
Wegovy has strong clinical trial data showing substantial weight loss and is the only weight-loss drug with FDA approval to reduce cardiovascular events. It requires a weekly injection and carries a boxed warning for thyroid C-cell tumors seen in animal studies. List price runs well above older weight-loss medications, and insurance coverage varies widely.
Pros
FDA-approved for long-term chronic weight management, not just short-term use
Only anti-obesity drug shown to reduce cardiovascular events in trials
Substantial average weight loss in clinical trials
Once-weekly dosing simplifies routine
Cons
Roughly $1,300 to $1,350 per month without insurance, before savings programs
Requires a subcutaneous injection rather than a pill
Boxed warning for thyroid C-cell tumors in animal studies
Common GI side effects like nausea and vomiting during dose increases
Phentermine
Phentermine has decades of real-world use and a low cost, making it accessible for short-term appetite suppression. As a Schedule IV controlled substance related to amphetamines, it carries risks of dependence, elevated heart rate, and increased blood pressure. It's approved only for a few weeks of use, not for the ongoing management most patients with obesity need.
Pros
Roughly $15 to $75 per month, far cheaper than many prescription options
Oral tablet, no injections needed
Long track record of use since 1959
Works quickly to reduce appetite
Cons
Approved only for short-term use (a few weeks), not chronic treatment
Controlled substance with risk of abuse and dependence
Can raise heart rate and blood pressure
No evidence of cardiovascular risk reduction
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.